Bayer AG Chief Executive Officer Marijn Dekkers
Chris Ratcliffe/Bloomberg
Bayer AG Chief Executive Officer Marijn Dekkers faces competition for the blood thinner Xarelto, Bayer’s biggest new drug, from a Pfizer Inc. product.
Bayer AG Chief Executive Officer Marijn Dekkers faces competition for the blood thinner Xarelto, Bayer’s biggest new drug, from a Pfizer Inc. product.